News
Clinical trials showed 99.9% of participants who received the drug, called Yeztugo from company Gilead Sciences, remained ...
15hon MSN
The US Food and Drug Administration (FDA) has approved lenacapavir, an injectable drug that offers long-lasting protection ...
A drug currently used to treat certain HIV infections has also, on Wednesday, received approval from the US Food and Drug ...
A newly approved HIV medication provides near-total protection against infection with just two injections a year. It's called Lenacapavir. But the high price of the drug could limit its reach.
The Food and Drug Administration approved the preventative use of lenacapavir, made by Gilead Sciences, on Wednesday. Experts ...
6d
MedPage Today on MSNFDA Approves Twice-Yearly Shot for HIV PreventionThe FDA approved lenacapavir (Yeztugo) as pre-exposure prophylaxis (PrEP) to reduce the risk of sexually acquired HIV-1 in at ...
Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the U.S. Food and Drug Administration (FDA) has approved Yeztugo® ...
6d
India Today on MSNLenacapavir becomes first FDA-approved HIV preventive drug: All about itThe US FDA has approved lenacapvir, sold under the brand name Yeztugo, as the first preventive treatment against HIV. It is a ...
The FDA approval marks the first approval of a type of pre-exposure prophylaxis that would only require 2 treatments per year ...
Utah biochemist Wesley Sundquist has achieved yet another milestone with the Food and Drug Administration approval of an ...
The approval of lenacapavir, a form of pre-exposure prophylaxis (PrEP), marks significant progress in preventing HIV, making it vital for the treatment to be available and accessible to those most ...
Lenacapavir is the latest HIV prevention shot to receive FDA approval. Apretude , made by GSK’s ViiV Healthcare, was the first injectable pre-exposure prophylaxis medication to receive approval ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results